These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10883468)

  • 21. Metabolic remission with octreotide in patients with insulinoma.
    von Eyben FE; Grodum E; Gjessing HJ; Hagen C; Nielsen H
    J Intern Med; 1994 Mar; 235(3):245-8. PubMed ID: 8120520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas.
    Nakamura A; Mitsuhashi T; Takano Y; Miyoshi H; Kameda H; Nomoto H; Nagai S; Hatanaka Y; Shimizu C; Terauchi Y; Atsumi T
    Endocr J; 2016; 63(2):135-42. PubMed ID: 26567922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative treatment of benign insulinoma: diazoxide or somatostatin analogues?
    Gilliaux Q; Bertrand C; Hanon F; Donckier JE
    Acta Chir Belg; 2022 Apr; 122(2):136-139. PubMed ID: 32375590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amelioration of hypoglycemia with octreotide therapy in metastatic insulinoma with positive octreotide scan.
    Wade AN; Cheng G; Teitelbaum U; Patel AA; Alavi A; Rickels MR
    Pancreas; 2011 Jan; 40(1):173-5. PubMed ID: 21160385
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH
    Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
    Arnold R; Neuhaus C; Trautmann ME
    Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
    [No Abstract]   [Full Text] [Related]  

  • 27. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia.
    Limmer S; Huppert PE; Juette V; Lenhart A; Welte M; Wietholtz H
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1097-101. PubMed ID: 19685572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Octreotide LAR was useful for avoiding hypoglycemia in an elderly patient with insulinoma].
    Kanno A; Ide K; Kurita K; Terano T; Yamamoto K
    Nihon Ronen Igakkai Zasshi; 2017; 54(2):172-178. PubMed ID: 28592737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An occult pancreatic insulinoma: radio-guided surgery with 111-In-octreotide. A case report and review of the literature on pre- and intraoperative diagnosis].
    Ressetta G; Geatti O; Pozzetto B; Sustersich M; Povolato M; Ferretti G; Leggeri A
    Ann Ital Chir; 2000; 71(1):107-12; discussion 113. PubMed ID: 10829532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulinoma and octreotide].
    Stehouwer C
    Ned Tijdschr Geneeskd; 1992 Jun; 136(25):1221. PubMed ID: 1614574
    [No Abstract]   [Full Text] [Related]  

  • 32. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review.
    Hearn PR; Ahmed M; Woodhouse NJ
    Horm Res; 1988; 29(5-6):211-3. PubMed ID: 2851522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective therapy of insulinoma by using long-acting somatostatin analogue. A case report and literature review.
    Jawiarczyk A; Bolanowski M; Syrycka J; Bednarek-Tupikowska G; Kałużny M; Kołodziejczyk A; Domosławski P
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):68-72. PubMed ID: 22187292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulinoma as rare cause of severe post-partum hypoglycemia.
    Holstein A; Morgenstern T; Dienst H; Hiller W
    J Obstet Gynaecol Res; 2015 Nov; 41(11):1848-50. PubMed ID: 26399682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of malignant insulinoma responsive to somatostatin analogs treatment.
    Caliri M; Verdiani V; Mannucci E; Briganti V; Landoni L; Esposito A; Burato G; Rotella CM; Mannelli M; Peri A
    BMC Endocr Disord; 2018 Dec; 18(1):98. PubMed ID: 30591061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulinoma in chronic renal failure: a case report.
    Basu A; Sheehan MT; Thompson GB; Service FJ
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4889-91. PubMed ID: 12414845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
    Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
    Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide.
    Longnecker SM
    Drug Intell Clin Pharm; 1988 Feb; 22(2):136-8. PubMed ID: 2894965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment: symptomatic treatment of hypoglycaemia.
    Tabarin A; Goichot B;
    Ann Endocrinol (Paris); 2013 Jul; 74(3):196-9. PubMed ID: 23791453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.